BCL2 and chronic myelogenous leukemia, BCR-ABL1 positive: Figure 6 shows that BP-CML cells treated with the Ad-AS-TK/GCV system, compared with Ad-S-TK/GCV or empty adenovirus, had more Bax expression, and decreased Bcl-2 and Cycline D1 expression.